1. Cytoskeleton
  2. Arp2/3 Complex
  3. Latrunculin A

Latrunculin A  (Synonyms: LAT-A)

目录号: HY-16929 纯度: ≥97.0%
COA 产品使用指南

Latrunculin A (LAT-A) 是一种 G-肌动蛋白聚合 (G-actin polymerization) 抑制剂,在红海海绵 Latrunculia magnifica 中发现的。Latrunculin A 能够与肌动蛋白 (actin) 单体结合,抑制其聚集,对 ATP-actin,ADP-Pi-actin,ADP-actin 和 G-actin 的 Kd 值分别为 0.1,0.4,4.7 μM 和 0.19 μM。Latrunculin A 具有有效的抗转移特性,可用于癌症的研究。Latrunculin A 抑制细胞迁移。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Latrunculin A Chemical Structure

Latrunculin A Chemical Structure

CAS No. : 76343-93-6

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 价格 是否有货 数量
100 μg (237.2 μM * 1 mL in Ethanol) ¥4300
In-stock

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Latrunculin A (LAT-A), found in the red sea sponge Latrunculia magnifica, is a G-actin polymerization inhibitor. Latrunculin A binds to actin monomers and inhibits polymerization of actin with Kds of 0.1, 0.4, 4.7 μM and 0.19 μM for ATP-actin, ADP-Pi-actin, ADP-actin and G-actin, respectively. Latrunculin A has effective anti-metastatic properties for cancer research. Latrunculin A blocks cell migration[1][2][3][4][5][6].

IC50 & Target

Kd: 0.1 μM (ATP-actin), 0.4 μM (ADP-Pi-actin), 4.7 μM (ADP-actin), 0.19 μM (G-actin)[2]

体外研究
(In Vitro)

LatruncuLin A (50-1000 nM) 对人前列腺癌 PC-3M 细胞具有强效抗侵袭活性,可抑制 PC-3M-CT+ 球体解聚和细胞迁移[3]
LatruncuLin A (3-30 μM) 抑制缺氧诱导的 HIF-1 激活,在人乳腺癌 T47D 细胞中的 IC50 值为 6.7 μM[3]
LatruncuLin A (0-0.2 μM,4 小时) 在高浓度 (例如 0.2 μM) 下对人肝癌 HepG2 细胞中的 HuR 水平具有显著抑制作用,而在 0.02 μM 时仅抑制 HuR,但在高浓度下对人肝癌 Huh7 没有抑制作用cells[4]
LatruncuLin A (0.1 μM,24 hours) 可导致细胞迁移显著减少,并对人肝癌细胞系 HepG2 的细胞增殖具有抑制作用[4]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

LatruncuLin A (腹腔注射,0.05 mg/kg,前20天分3次给药,120天) 对感染腺癌 (MKN45) 或癌 (NugC-4) 的雄性BALB/c裸鼠模型具有较强的抗肿瘤作用[5]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male BALB/c nude mice models infected with adenocarcinoma (MKN45) or carcinoma (NUGC-4)[5]
Dosage: 0.05 mg/kg
Administration: Intraperitoneal injection; three doses in the first 20 days; 120 days
Result: Extended the mean life expectancy to 23.5 days comparing to control of 16 days in adenocarcinoma (MKN45) mice and the mean survival time was 42 days comparing to untreated of 31 days in carcinoma (NUGC-4) mice.
Clinical Trial
分子量

421.55

Formula

C22H31NO5S

CAS 号
性状

液体

颜色

Colorless to light yellow

结构分类
初始来源

red sea sponge Latrunculia magnifica

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Solution, -20°C, 2 years

纯度 & 产品资料

纯度: ≥98.0%

参考文献

Latrunculin A 相关分类

  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Latrunculin A
目录号:
HY-16929
需求量: